29/08/2024  08:06:22 Var. -1.500 Volume Denaro19:56:08 Lettera19:56:08 Capitalizzazione di mercato Dividend Y. Rapporto P/E
263.900EUR -0.57% -
Fatturato: -
282.400Quantità in denaro: 2,000 287.000Quantità in lettera: 2,000 20.54 bill.EUR - -

Descrizione business

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Eric M. Green
Consiglio di amministrazione
Bernard J. Birkett, Annette F. Favorite, Chris Ryan, Cindy Reiss-Clark, Dr. Quintin Lai, Kimberly Banks MacKay, Silji Abraham, Kathy dePadua
Consiglio di sorveglianza
Eric M. Green, Deborah Keller, Douglas A. Michels, Mark Buthman, Molly E. Joseph, Myla Lai-Goldman, M.D., Paolo Pucci, Robert Friel, Thomas W. Hofmann, Stephen Lockhart, William F. Feehery
 

Dati aziendali

Name: West Pharmaceutical Services Inc.
Indirizzo: 530 Herman O. West Drive,Exton, PA 19341-0645, USA
Telefono: +1-610-594-2900
Fax: -
E-mail: west.pharmaceutical....rma.com west.pharmaceutical.services@westpharma.com
Internet: www.westpharma.com
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 67.50%
Data dell'IPO: -

Rapporti con gli investitori

Name: Dr. Quintin Lai
IR telefono: +1-610-594-3318
IR Fax: -
IR e-mail: Quintin.Lai@westpharma.com

Principali azionisti

Altri
 
51.78%
Vanguard Group Inc
 
12.35%
BlackRock Inc.
 
10.67%
The Bank of New York Mellon Corp.
 
4.57%
State Street Corporation
 
4.49%
Price T Rowe Associates Inc Md
 
3.19%
APG Asset Management N V
 
3.15%
Franklin Resources Inc.
 
2.89%
Artisan Partners Limited Partnership
 
2.69%
Altri
 
4.22%